Specify a stock or a cryptocurrency in the search bar to get a summary
Electrocore LLC
ECORelectroCore, Inc., a commercial-stage bioelectronic medicine and wellness company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults; Truvaga for the support of general health and wellbeing; and TAC-STIM, a form of nVNS for human performance. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey. Address: 200 Forge Way, Rockaway, NJ, United States, 07866
Analytics
WallStreet Target Price
22.75 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ECOR
Dividend Analytics ECOR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ECOR
Stock Valuation ECOR
Financials ECOR
Results | 2019 | Dynamics |